AOCNP Survivorship and Long-Term Follow-Up

Question 1

According to the ONCC AOCNP framework, survivorship care planning begins at which point in the cancer continuum?

Accepted Answer

At the time of diagnosis and continues throughout treatment and beyond

Answer

Only after the patient is declared cancer-free

Answer

After 5 years of disease-free survival

Answer

Only when the patient transitions off active treatment

Question 2

Chemotherapy-induced peripheral neuropathy (CIPN) most commonly occurs with which drug class?

Accepted Answer

Platinum compounds (oxaliplatin, cisplatin) and taxanes (paclitaxel)

Answer

Anthracyclines (doxorubicin)

Answer

Alkylating agents (cyclophosphamide)

Answer

Topoisomerase inhibitors (irinotecan)

Question 3

Aromatase inhibitor (AI)-induced arthralgias affect a significant percentage of breast cancer survivors. Which intervention has the strongest evidence for relieving AI-associated musculoskeletal symptoms?

Accepted Answer

Aerobic and resistance exercise programs

Answer

Opioid analgesics scheduled around the clock

Answer

Switching to a different aromatase inhibitor as the first intervention

Answer

Routine NSAIDs scheduled daily

Question 4

Post-treatment surveillance guidelines for breast cancer survivors typically include clinical examination every 3–6 months for the first 3 years, then annually, combined with:

Accepted Answer

Annual mammography of remaining breast tissue

Answer

Annual PET/CT scan

Answer

Annual CA 15-3 serum marker measurement

Answer

Semi-annual CT chest/abdomen/pelvis

Question 5

Cancer-related cognitive impairment (CRCI or 'chemo brain') is characterized by which cluster of symptoms?

Accepted Answer

Subtle deficits in memory, attention, processing speed, and executive function

Answer

Frank dementia with loss of long-term memory

Answer

Severe aphasia and motor dysfunction

Answer

Psychosis and personality changes

Question 6

Which organization provides the standardized Survivorship Care Plan template most widely recommended by oncology professional bodies?

Accepted Answer

ASCO (American Society of Clinical Oncology)

Answer

CDC (Centers for Disease Control)

Answer

ONCC (Oncology Nursing Certification Corporation)

Answer

NCCN (National Comprehensive Cancer Network)